These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23965539)

  • 1. Quality-control analytical methods: pharmacopeial bacterial endotoxins test chapters.
    Dawson ME
    Int J Pharm Compd; 2010; 14(4):317-20. PubMed ID: 23965539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basics of compounding: application of the United States pharmacopeia bacterial endotoxins test to compounded sterile preparations.
    Dawson MF
    Int J Pharm Compd; 2006; 10():36-9. PubMed ID: 23974125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-control analytical methods: endotoxins: essential testing for pyrogens in the compounding laboratory, part 3: a simplified endotoxin test method for compounded sterile preparations.
    Cooper JF
    Int J Pharm Compd; 2011; 15(1):49-54. PubMed ID: 23696047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy.
    Cooper JF; Latta KS; Smith D
    Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice.
    Kelley B
    Int J Pharm Compd; 2021; 25(2):115-124. PubMed ID: 33798111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(6):492-9. PubMed ID: 23994811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 9: immediate use compounded sterile preparations.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(5):440-3. PubMed ID: 23969870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(2):136-44. PubMed ID: 23969607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(1):54-60. PubMed ID: 23969573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(4):313-23. PubMed ID: 23974791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2010; 14(2):142-9. PubMed ID: 23965426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality Assurance and Quality Control, Part 1.
    Akers MJ
    Int J Pharm Compd; 2015; 19(2):121-4. PubMed ID: 26685493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(3):252-7. PubMed ID: 23969716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(4):344-53. PubMed ID: 23969772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-control analytical methods: endotoxins: essential testing for pyrogens in the compounding laboratory, part2.
    Cooper JF; Chakrabarty K; McGuire J; Zolner WJ; Jones V; Hedman H
    Int J Pharm Compd; 2010; 14(6):493-506. PubMed ID: 23965654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4.
    Allen LV
    Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-Control Analytical Methods: Microbial-Testing Aspects of USP Chapter 797 for Compounded Sterile Preparations.
    Kupiec TC
    Int J Pharm Compd; 2005; 9(1):47-9. PubMed ID: 23924865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations.
    Allen LV
    Int J Pharm Compd; 2021; 25(6):491-496. PubMed ID: 34807845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations.
    Okeke CC; Allen LV
    Int J Pharm Compd; 2010; 14(1):60-4. PubMed ID: 23965372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.